ArticleTropical animal health and production2025
Assessing the effect of a yeast product (Pichia guilliermondii) on growth performance, carcass traits, gut morphology, intestinal microbial computation, and immune response in broilers.
Article in Tropical animal health and production, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study evaluated the effects of Pichia guilliermondii supplementation on broiler growth performance, carcass traits, gut morphology, microbiota, and immune response over a 35-day period. A total of 240 chicks were randomly assigned to four dietary treatments: a control group and three experimental groups receiving 0.05%, 0.1%, and 0.15% yeast supplementation, each with six replicates of 10 birds each. Data were analyzed using a one-way ANOVA under a completely randomized design. Birds supplemented with 0.15% yeast tended to increase the weight gain, while all yeast-treated groups exhibited significantly improved feed conversion ratios (P < 0.05) compared to the control group. The 0.05% group showed significantly higher live weights and numerical increases in carcass weights, both with and without giblets. Leg quarter yield tended to improve in both the 0.05% and 0.15% groups, while gizzard weight significantly increased (P < 0.05) in the 0.05% group. Histological analysis revealed a marked increase in villus height and a reduction in crypt depth (P < 0.0001) in all yeast-treated groups, with higher inclusion levels enhancing the villus height-to-crypt depth ratio. All yeast-treated groups exhibited significantly elevated antibody titers against Newcastle disease on days 20 and 35. Microbial analysis indicated increased Lactobacilli and reduced Salmonella counts in the 0.15% group. Economically, the 0.05% yeast group yielded the highest profit per bird. Overall, Pichia guilliermondii supplementation—particularly at 0.05%—proved to be a cost-effective and sustainable strategy for improving broiler performance, health, and profitability.
Indexed as
Identifiers
41021064What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.